These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30793229)

  • 1. Spindle cell liposarcoma with a TRIO-TERT fusion transcript.
    Suster DI; Deshpande V; Chebib I; Taylor MS; Mullen J; Bredella MA; Nielsen GP
    Virchows Arch; 2019 Sep; 475(3):391-394. PubMed ID: 30793229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanished MDM2 amplification in multiple recurrences of an irradiated poorly differentiated sarcoma with amplified TRIO::TERT fusion gene.
    Goffinet S; Di Mauro I; Doyen J; Boyer J; Birtwisle-Peyrottes I; Keslair F; Pedeutour F; Dadone-Montaudie B
    Genes Chromosomes Cancer; 2023 Jun; 62(6):342-352. PubMed ID: 36916207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent TRIO Fusion in Nontranslocation-Related Sarcomas.
    Delespaul L; Lesluyes T; Pérot G; Brulard C; Lartigue L; Baud J; Lagarde P; Le Guellec S; Neuville A; Terrier P; Vince-Ranchère D; Schmidt S; Debant A; Coindre JM; Chibon F
    Clin Cancer Res; 2017 Feb; 23(3):857-867. PubMed ID: 27528700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
    Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
    Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
    Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
    Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report.
    Grifasi C; Calogero A; Carlomagno N; Campione S; D'Armiento FP; Renda A
    World J Surg Oncol; 2013 Nov; 11():305. PubMed ID: 24279301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].
    Pedeutour F; Maire G; Sirvent N;
    Bull Cancer; 2004 Apr; 91(4):317-23. PubMed ID: 15242313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
    Boland JM; Colby TV; Folpe AL
    Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel CTNND2-TERT fusion in a spindle cell liposarcoma.
    Occidental M; Shen G; Feng X; Zhu K; Kelly K; Nie Q; Reddi HV; Lakiotaki E; Viniou NA; Korkolopoulou P; Linos K; Jour G
    Genes Chromosomes Cancer; 2020 Sep; 59(9):544-548. PubMed ID: 32352179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
    Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
    Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare myxoid pleomorphic liposarcoma: a case report and literature review.
    Shen Y; Zhao L; Li A; Peng Q; Liu Q; Wang L; Liu Z
    J Clin Pathol; 2024 Apr; 77(5):358-362. PubMed ID: 38123348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases.
    Boland JM; Weiss SW; Oliveira AM; Erickson-Johnson ML; Folpe AL
    Am J Surg Pathol; 2010 Jun; 34(6):837-43. PubMed ID: 20431480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
    J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K; Flora R; Shah C; Olmos D; Fisher C
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxoid pleomorphic liposarcoma-a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma.
    Creytens D; Folpe AL; Koelsche C; Mentzel T; Ferdinande L; van Gorp JM; Van der Linden M; Raman L; Menten B; Fritchie K; von Deimling A; Van Dorpe J; Flucke U
    Mod Pathol; 2021 Nov; 34(11):2043-2049. PubMed ID: 34168281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
    Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
    Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDIT3-amplified or low-polysomic pleomorphic sarcomas without MDM2 amplification: Clinicopathological review and immunohistochemical profile of nine cases.
    Mori T; Iwasaki T; Sonoda H; Kawaguchi K; Tomonaga T; Furukawa H; Sato C; Shiraishi S; Taguchi K; Tamiya S; Yoneda R; Oshiro Y; Matsunobu T; Abe C; Kuboyama Y; Ueki N; Kohashi K; Yamamoto H; Nakashima Y; Oda Y
    Hum Pathol; 2024 Mar; 145():56-62. PubMed ID: 38401716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of MDM2 Fluorescence In Situ Hybridization and Immunohistochemistry in Distinguishing Dedifferentiated Liposarcoma From Other High-grade Sarcomas.
    Song MJ; Cho KJ; Lee JS; Song JS
    Appl Immunohistochem Mol Morphol; 2017; 25(10):712-719. PubMed ID: 27028243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.